Contact this trialFirst, we need to learn more about you.
Small molecule
LNS8801 + Pembrolizumab for Cancer
Recruiting1 awardPhase 1 & 2
New York, New York
This trial is testing a new drug, LNS8801, to see if it is safe and works well against cancer. Up to 200 patients will be enrolled at up to 10 sites in the United States.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.